Shareholders Equity: The sum of preferred and common equity items.
Belite Bio, Inc. Sponsored ADR (BLTE) had Shareholders Equity of $149.88M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-16.32M |
|
-- |
|
-- |
|
$17.60M |
|
$-17.60M |
|
$1.28M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-16.32M |
|
$-17.60M |
|
$-17.60M |
|
32.59M |
|
32.59M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$150.97M |
|
-- |
|
$5.44M |
|
$156.41M |
|
$6.52M |
|
-- |
|
-- |
|
$6.52M |
|
-- |
|
$149.88M |
|
|
Shareholders Equity |
$149.88M |
32.60M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.89% |
|
-10.43% |
|
-10.89% |
|
$4.60 |
|
-- |
|
-- |
|